Anzeige
Mehr »
Samstag, 16.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41EP1 | ISIN: US92943X1046 | Ticker-Symbol: H1O
NASDAQ
15.08.25 | 21:47
14,250 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VYOME HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
VYOME HOLDINGS INC 5-Tage-Chart

Aktuelle News zur VYOME Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrVyome to leverage US-India ties to tackle $100B immuno-inflammatory market1
FrVyome to begin trading as Vyome Holdings under HIND symbol7
DoReShape Lifesciences Inc. - 10-Q, Quarterly Report6
MiNach Fusion mit ReShape Lifesciences: Vyome Therapeutics startet an der NASDAQ unter dem Kürzel HIND2
MiVyome Therapeutics to list on nasdaq as HIND after ReShape Lifesciences merger1
MiVyome Therapeutics Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND462Effective as of Commencement of Trading on August 15, 2025 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare...
► Artikel lesen
DiVyome to replace ReShape Lifesciences leadership as it prepares for Nasdaq listing1
VYOME Aktie jetzt für 0€ handeln
MoReShape Lifesciences Inc. - 8-K, Current Report2
07.08.ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics114Expected to be Effective as of Commencement of Trading on August 15, 2025 IRVINE, Calif.--(BUSINESS WIRE)--ReShape Lifesciences® (Nasdaq: RSLS) announced today that its shareholders have approved...
► Artikel lesen
25.07.ReShape Lifesciences Inc. - 8-K, Current Report2
24.07.ReShape Lifesciences Inc: ReShape Lifesciences Announces Partial Adjournment of Special Meeting of Stockholders2
22.07.ReShape Lifesciences Inc: ReShape Lifesciences to Host Inaugural Lap-Band Surgeon Summit3
21.07.ReShape Lifesciences Inc: ReShape Lifesciences to Host Special Meeting of Stockholders on July 24, 20252
15.07.ReShape Lifesciences Inc. - 8-K, Current Report1
03.07.ReShape Lifesciences Inc. - 8-K, Current Report1
01.07.ReShape Lifesciences Inc: ReShape Lifesciences Granted U.S. Patent Related to an Intragastric Balloon System157IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that on July 8...
► Artikel lesen
27.06.ReShape Lifesciences regains Nasdaq compliance2
27.06.ReShape Lifesciences regains Nasdaq compliance after equity raises1
27.06.ReShape Lifesciences Inc: ReShape Lifesciences Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement396IRVINE, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that on June...
► Artikel lesen
26.06.ReShape Lifesciences Intends To Reduce Workforce To Boost Operational Efficiency1
Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1